It says BIEL is in "discussions" with a global player, and BIEL's "intended" relationship is as an OEM partner. Key words are. in "discussions" with, "intended relationship" and "expected to generate". This is from Dec. 16, it is now June 11, and we've heard nothing. Did Mundipharma get the needed regulatory clearances for those countries needing it? We don't know, we don't know anything except the 180 day tweet hashtag journey is over. We should get the late fins in 4 days on Monday. That should reveal some of the items we don't know about. BIEL has always placed the burdens on distributors for Marketing/Sales it's in their distributor agreements. Look where it has gotten us. JMHO